Pharma & Bio
Technology
‘Riboceranib Optimism’ Boosts HLB INC. Affiliates… SAM CHUN DANG PHARM CO. LTD Rises for 5 Consecutive Days [Bio Spotlight]
On the 6th, in the biotech sector, the stock prices of affiliates of the HLB INC.(028300) Group—which received South Korea’s first-ever approval from the U.S. Food and Drug Administration (FDA) for a …
- 2026-10-08 07:36:02
- KIM SUNG-JIN
Technology
“Enforcing Patent Rights” vs. “No Infringement”… Precision Biosensor Inc. and SD Bio Clash Over Animal Diagnostic Devices
Precision Biosensor Inc.(335810)Precision Biosensor Inc. and SD Biosensor(137310)(SD Biosensor) are locked in a dispute over a patent applied to veterinary diagnostic equipment. Precision Biosensor In…
- 2026-10-07 13:31:03
- NA EUN-KYUNG
Technology
AprilBio Plunges 20%; Peptron Dampens Hopes for a Lilly Deal [K-Bio Pulse]
South Korean biotech stocks came under pressure on Oct. 2, with AprilBio Co., Ltd. plunging 20% despite the release of additional Phase 2a data for its atopic dermatitis candidate, APB-R3. Peptron Inc…
- 2026-10-07 09:12:02
- KIM SAE-MI
Technology
AprilBio Co.,Ltd.’s ‘APB-R3’ Data Triggers 20% Drop… Peptron, Inc. Draws a Line on ‘Lilly Expectations’ [Bio Spotlight]
On the 2nd, in the biotech sector, additional detailed data from the Phase 2a clinical trial of AprilBio Co.,Ltd.(397030)’s atopic dermatitis treatment “APB-R3” was released, but the stock price plumm…
- 2026-10-07 09:11:02
- KIM SAE-MI
Lifestyle
BIOBIJOU Co., Ltd., a Huge Hit in the U.S., Expected to Post Record Earnings This Year...Next Year Looks Even Better
#BIOBIJOU Co., Ltd., a company specializing in aesthetic medical devices, is on track to post its best-ever annual results after achieving a steep quantum leap in performance, driven primarily by the …
- 2026-10-07 08:02:02
- YU JIN-HEE
Lifestyle
DaewonPharmaceutical Makes a Bold Move in the 55 Billion Hyperlipidemia Market... 'Overwhelming Efficacy + 43% Smaller Tablet Size'
DaewonPharmaceutical(003220)has set its sights on the 55 billion won hyperlipidemia (dyslipidemia) market by highlighting its “small pill,” which is 43% smaller in volume, and the fact that it can be …
- 2026-10-07 07:51:02
- KIM JI-WAN
Technology
Biotech Special Listing Faces ‘Numerical Hurdle’; ‘Visibility of Commercialization’ Is the Key to Success
(Graphic: ChatGPT)
The “numerical barrier” is rising for pharmaceutical and biotech companies preparing for a KOSDAQ listing under the technology exception category. The prevailing sentiment is th…
- 2026-10-07 07:31:03
- Minji Son
Technology
ROKIT HEALTHCARE Inc. Promotes “Hair Follicle Rejuvenation”… Evidence Supporting “65% Hair Regrowth” Remains Limited
(Graphic: ChatGPT)
#ROKIT HEALTHCARE Inc. announced the results of its second round of animal testing for a naturally derived photobiomodulation (PBM) candidate compound, touting groundbreaking cl…
- 2026-10-07 07:26:03
- Minji Son
Technology
Kang Seong-ji, CEO of Welt: “Cognitive Behavioral Therapy Is a Map, Patients Are Reality… DTx Must Be the Navigation System”
“Cognitive behavioral therapy is like a roadmap that outlines the basic principles and direction of treatment. Going forward, it must evolve into an approach that guides treatment based on each patien…
- 2026-10-07 07:07:02
- Kim Seung-kwon
Technology
[Caregen Co.,LTD. Deep Seek ②] 'Progestrol,' Which Cleared the U.S. FDA, Has Been Stalled for Four Years in Its Bid to Gain Approval from the Korean Ministry of Food and Drug Safety
Caregen Co.,LTD.(214370)CareGen is delaying its application for domestic “individual recognition” status as a health functional food ingredient for “ProGsterol,” a blood sugar management product that …
- 2026-10-07 07:01:02
- KIM SAE-MI
PHARM EDAILY
Shorts